Director of the Gradus/RSJ Life Sciences Fund; Director of Global Business Development of PrimeCell Therapeutics, overseeing the expansion of the largest regenerative medicine company in Central Europe; Analyst and advisor to Amgen, Novartis, Eli Lilly, Allergan, EMD, Serono, and Sanofi; MD from the Medical Faculty of Charles University in Prague